Glenn Allen Held

Title: Glenn Allen Held: Innovating at the Intersection of Gene Expression and Light Modulation

Introduction

Glenn Allen Held, based in Pelham, NY, is an accomplished inventor with a significant contribution to the field of biotechnology and optical devices. With a total of three patents to his name, Held has demonstrated remarkable creativity and expertise in his areas of focus, showcasing innovative solutions that hold great potential for various applications.

Latest Patents

Held's most recent inventions include a method and apparatus for determining gene expression levels and a liquid crystalline light-modulating device.

The first patent outlines a technique that provides a method for determining the concentration level of a target nucleic acid. This innovative process involves measuring the affinity value of the target oligonucleotide with a probe oligonucleotide, along with the hybridization intensity at a probe spot. These metrics work in tandem to accurately ascertain the concentration level of the target nucleic acid, a crucial advancement for gene expression analysis.

The second patent revolves around a light-modulating composition that includes a low molecular weight liquid crystalline material dispersed in a polymer. This invention involves the reaction of a non-mesogenic crosslinking monomer with a mesogenic monomer to create a sophisticated light-modulating device, potentially useful in various optical applications.

Career Highlights

Glenn Allen Held is currently associated with the International Business Machines Corporation (IBM), where he pushes the boundaries of technology through research and development. His deep understanding of multi-disciplinary fields enables him to connect complex concepts, leading to groundbreaking innovations.

Collaborations

Throughout his career, Held has collaborated with notable colleagues including Do Yeung Yoon and Shui-Chih Alan Lien. These partnerships foster a dynamic environment for knowledge exchange and innovative thinking, contributing to the success of their collective endeavors.

Conclusion

Glenn Allen Held's contributions to gene expression analysis and light modulation reflect his commitment to advancing technology and science. As he continues to innovate at IBM, his work will likely pave the way for new technological breakthroughs that could transform industries ranging from healthcare to consumer electronics. His impressive patent portfolio is a testament to his ingenuity and impact as an inventor.